Figure 4.
Kaplan-Meier survival curves for the entire cohort (N = 132) stratified based on the TP53 mutation status. (A) PFS and (B) OS of patients with (TP53-mutated; red) or without (TP53-unmutated; blue) PTCL. Data of living patients were censored at the time of last follow-up (filled circles). The number of patients at risk for each time point and cohort is shown.